Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F C Grumet

Showing results (11-20 of 140) with videos related to

Pageof 14
Sort By:
Human Immunology|December 1, 1983
Detection of platelet antibodies by anti-kappa light chain facilitation of C-FDA (KC-FDA) thrombocytotoxicityG E Lizak, F C Grumet
Transplantation|April 1, 1970
Inhibition of the response in mixed leukocyte cultures by alloimmune plasmaF C Grumet, B G Leventhal
Transplantation|February 1, 1972
Genetic control of the immune response. Relationship between the immune response-1 gene(s) and individual H-2 antigenic specificitiesF C Grumet, H O McDevitt
Transplantation Proceedings|March 1, 1973
Suppression of anti-(T,G)-A--L antibody production in nonresponder miceJ C Ordal, F C Grumet
Pediatrics|May 1, 1982
Posttransfusion cytomegalovirus infectionsS G Sandler, F C Grumet
Annals of Internal Medicine|July 1, 1970
Long-term platelet support of patients with aplastic anemia. Effect of splenectomy and steroid therapyF C Grumet, R A Yankee
Human Immunology|July 1, 1980
A new micromethod for the in vitro detection of antiplatelet antibodies: C-FDA thrombocytotoxicityG E Lizak, F C Grumet
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1982
Mechanism of enhanced complement-dependent cytotoxicity of papain-treated lymphocytes: evidence for increased stability of classical pathway C3 convertaseD M Lublin, F C Grumet
Transplantation|August 1, 1979
Platelet transfusion tolerization by liver membrane treatmentR M Osborne, F C Grumet
Journal of Clinical Pathology|February 1, 1979
Storage of reagent platelets for anti-platelet antibody testing in the 51Cr platelet lysis assayG E Lizak, F C Grumet
Pageof 14

Showing results (11-20 of 140) with videos related to

Sort By:
Pageof 14
Human Immunology|December 1, 1983
Detection of platelet antibodies by anti-kappa light chain facilitation of C-FDA (KC-FDA) thrombocytotoxicityG E Lizak, F C Grumet
Transplantation|April 1, 1970
Inhibition of the response in mixed leukocyte cultures by alloimmune plasmaF C Grumet, B G Leventhal
Transplantation|February 1, 1972
Genetic control of the immune response. Relationship between the immune response-1 gene(s) and individual H-2 antigenic specificitiesF C Grumet, H O McDevitt
Transplantation Proceedings|March 1, 1973
Suppression of anti-(T,G)-A--L antibody production in nonresponder miceJ C Ordal, F C Grumet
Pediatrics|May 1, 1982
Posttransfusion cytomegalovirus infectionsS G Sandler, F C Grumet
Annals of Internal Medicine|July 1, 1970
Long-term platelet support of patients with aplastic anemia. Effect of splenectomy and steroid therapyF C Grumet, R A Yankee
Human Immunology|July 1, 1980
A new micromethod for the in vitro detection of antiplatelet antibodies: C-FDA thrombocytotoxicityG E Lizak, F C Grumet
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1982
Mechanism of enhanced complement-dependent cytotoxicity of papain-treated lymphocytes: evidence for increased stability of classical pathway C3 convertaseD M Lublin, F C Grumet
Transplantation|August 1, 1979
Platelet transfusion tolerization by liver membrane treatmentR M Osborne, F C Grumet
Journal of Clinical Pathology|February 1, 1979
Storage of reagent platelets for anti-platelet antibody testing in the 51Cr platelet lysis assayG E Lizak, F C Grumet
Pageof 14